Your A-Z of episodes
Did you know there’s even more we can do to promote your episode? Find out more…
-
Episode 192
Tasty Topics: Navigating Novo Nordisk’s Acquisition of Catalent
Dirk Lange, Brett Alderson, John Cameron & Janet Hoogstraate
/ Pyramid Labs, NovaCina, Corden Pharma & NorthX Biologics
Hear sector experts discuss the potential impacts of Novo’s acquisition of Catalent and maximizing GLP-1 manufacturing capacity.
-
Episode 186
The VC Biotech investor
Chris Garabedian
/ Xontogeny
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Chris Garabedian, CEO at Xontogeny and Venture Fund Manager at Perceptive Advisors. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Chris, covering: Chris Garabedian founded Xontogeny in June of 2016 to …
- Load more